Placental growth factor in the first trimester: Relationship with maternal factors and placental Doppler studies

Ultrasound in Obstetrics and Gynecology

Volumn 35, Issue 3, 2010, Pages 280-285

  Kasdaglis, T ^a   Aberdeen, G ^a   Turan, O ^a   Kopelman, J ^a   Atlas, R ^a   Jenkins, C ^a   Blitzer, M ^a   Harman, C ^a   Baschat, A A ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Doppler; First trimester; Placenta; Placental growth factor; PlGF

Indexed keywords

BIOLOGICAL MARKER; GROWTH HORMONE; HGH V PROTEIN, HUMAN; HGH-V PROTEIN, HUMAN; PLACENTA PROTEIN; PLACENTAL GROWTH FACTOR; PLACENTAL PEPTIDE HORMONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; CLINICAL TRIAL; ECHOGRAPHY; EVALUATION; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL AGE; MULTICENTER STUDY; NEWBORN; PARITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY; PROSPECTIVE STUDY; REPRODUCTION; VASCULAR RESISTANCE; VASCULARIZATION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; GROWTH HORMONE; HUMANS; INFANT, NEWBORN; MATERNAL AGE; PARITY; PLACENTA; PLACENTAL HORMONES; PLACENTATION; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PROSPECTIVE STUDIES; VASCULAR RESISTANCE; YOUNG ADULT;

EID: 77949581571     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.7548     Document Type: Article

References (18)

1. Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 2000; 92: 35-43.
2. Maternal adaptations to pregnancy. In Williams Obstetrics, Cunningham FG, Hauth JC, Wenstrom KD, Leveno KJ, Gilstrap III LC, Bloom SL (eds). McGraw-Hill: New York, 2005; 167-200.
3. Papageorghiou AT, Yu C, Erasmus I, Cuckle H, Nicolaides K. Assessment of risk for the development of pre-eclampsia by maternal characteristics and uterine artery Doppler. BJOG 2005; 112: 703-709.
4. Poon L, Kametas N, Pandeva I, Valencia C, Nicolaides K. Mean arterial pressure at 11(+0) to 13(+)6 weeks in the prediction of preeclampsia. Hypertension 2008; 51: 1027-1033.
5. Clark DE, Smith SK, Licence D, Evans AL, Charnock-Jones DS. Comparison of expression patterns for placenta growth factor, vascular endothelial growth factor (VEGF), VEGF-B and VEGF- C in the human placenta throughout gestation. J Endocrinol 1998; 159: 459-467.
6. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001; 184: 1267-1272.
7. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683.
8. Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Gonçalves LF, Medina L, Edwin S, Hassan S, Carstens M, Gonzalez R. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007; 196: 326.e1-326.e13.
9. Savvidou MD, Akolekar R, Zaragoza E, Poon LC, Nicolaides KH. First trimester urinary placental growth factor and development of pre-eclampsia. BJOG 2009; 116: 643-647.
10. Spencer K, Heath V, El-Sheikhah A, Ong CY, Nicolaides KH. Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro-Caribbean populations. Prenat Diagn 2005; 25: 365-369.
11. Spencer K, Bindra R, Cacho AM, Nicolaides KH. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 2004; 24: 169-173.
12. Nicolaides KH. First-trimester screening for chromosomal abnormalities. Semin Perinatol 2005; 29: 190-194.
13. Campbell S, Platt L. The publishing of papers on first- trimester Doppler. Ultrasound Obstet Gynecol 1999; 14: 159-160.
14. Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008; 32: 732-739.
15. Savvidou MD, Noori M, Anderson JM, Hingorani AD, Nicolaides KH. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation. Ultrasound Obstet Gynecol 2008; 32: 871-876.
16. Makrydimas G, Sotiriadis A, Savvidou MD, Spencer K, Nicolaides KH. Physiological distribution of placental growth factor and soluble Flt-1 in early pregnancy. Prenat Diagn 2008; 28: 175-179.
17. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21: 9-23.
18. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53: 812-818.